Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Obesity
Biotech
Rivus weight loss drug shows MASH win, muscle-sparing potential
Rivus’ fat-busting, muscle-sparing drug candidate reduced liver fat in a phase 2 trial while showcasing the drug's obesity potential.
James Waldron
Jun 24, 2025 10:07am
Amgen's ph. 3 MariTide study will ramp up dosing to quell nausea
Jun 24, 2025 9:59am
Zealand's dual agonist tied to 11% weight loss in phase 1b
Jun 18, 2025 3:00pm
Scholar Rock's SMA drug helps Zepbound patients retain muscle
Jun 18, 2025 9:10am
Turkish bank invests $39M in Harvard next-gen obesity antibodies
Jun 16, 2025 1:07pm
South Korean biotech's GLP-1 scores MASH win, reduces weight
Jun 16, 2025 7:22am
